OSCR — Oscar Health Income Statement
0.000.00%
- $3.32bn
- $975.94m
- $11.70bn
Annual income statement for Oscar Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Premiums Earned | |||||
| Net Investment Income | |||||
| Realized & Unrealized Gains / Losses | |||||
| Total Revenue | 1,839 | 3,964 | 5,863 | 9,178 | 11,701 |
| Losses, Benefits, and Adjustments | |||||
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2,403 | 4,554 | 6,098 | 9,120 | 12,098 |
| Operating Profit | -565 | -590 | -236 | 57.3 | -396 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -571 | -610 | -267 | 33.4 | -437 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -571 | -610 | -271 | 26.1 | -443 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -573 | -606 | -271 | 25.4 | -443 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -573 | -606 | -271 | 25.4 | -443 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.12 | -2.85 | -1.22 | 0.096 | -1.69 |
| Dividends per Share |